BSE filing, NSE: PCCOSMA. Summary written from the filing by ALFA Finder's alert engine.
Pee Cee Cosma Sope Ltd: key numbers
- Share price
- ₹433.10
- Market cap
- ₹114.6 Cr
- Revenue (annual)
- ₹158.0 Cr
- Net profit (annual)
- ₹8.33 Cr
- P/E (TTM)
- 13.2×Sector 38.3×
- Promoter holding
- 72.58%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pee Cee Cosma Sope Ltd
All →Pee Cee Cosma Sope Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Pee Cee Cosma Sope Annual General Meeting
Pee Cee Cosma Sope Ltd. held its 39th Annual General Meeting on September 29, 2026, approving the financial statements and a final dividend of Rs. 3 per share.
Pee Cee Cosma Sope Annual Report
Pee Cee Cosma Sope Ltd has released its Annual Report for FY 2025-26. The company convened its 39th AGM for September 29, 2026, to approve a 30% dividend.
Pee Cee Cosma Sope Annual General Meeting
Pee Cee Cosma Sope Ltd will hold its 39th AGM on September 29, 2026. Shareholders will consider a final dividend of Rs. 3 per equity share.
Pee Cee Cosma Sope Q1 FY27 Results: Net Profit ₹3.3 Cr, Up 13.8% YoY
Pee Cee Cosma Sope Ltd reported revenue from operations of ₹49.3 Cr (+23.2% YoY) and net profit of ₹3.3 Cr (+13.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.3 Cr · +13.8% YoY
Pee Cee Cosma Sope Merger & Restructuring Worth ₹5 Cr
Pee Cee Cosma Sope Ltd's board approved a Rs. 5.00 Crore investment in its wholly-owned subsidiary, India Trading Infra Limited. The capital infusion supports business expansion and liquidity.
- Value
- ₹5.00 Cr
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr